skip to Main Content

OM1

Invested in 2019

01/2015
Company founded
12/2019
Scale leads $50M Series C

OM1 uses machine learning to create unique datasets based on real-world evidence that help healthcare companies accelerate regulatory approvals and better measure ROI.

Related resources

Scale team

Rory O’Driscoll

Partner

Back To Top